About HLB
HLB is a company based in Ulsan (South Korea) founded in 1985.. The company has 168 employees as of December 31, 2024. HLB has completed 2 acquisitions, including Anygen and GtreeBNT. HLB offers products and services including Rivoceranib and Other Therapies.
- Headquarter Ulsan, South Korea
- Employees 168 as on 31 Dec, 2024
- Stage Public
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hlb Co., Ltd.
-
Annual Revenue
$46.19 M (USD)58.8as on Dec 31, 2024
-
Net Profit
$-62.36 M (USD)50.96as on Dec 31, 2024
-
EBITDA
$-76.23 M (USD)-5.74as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
168
as on Dec 31, 2024
-
Investments & Acquisitions
Anygen
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HLB
HLB is a publicly listed company on the KRX with ticker symbol 028300 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of HLB
HLB offers a comprehensive portfolio of products and services, including Rivoceranib and Other Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rivoceranib is positioned as a targeted therapy for various cancers, including liver and lung cancers, that is developed to meet specific medical needs
Other therapies such as CAR-T and immune therapies are offered under HLB's pharmaceutical portfolio to address a range of oncology applications
Funding Insights of HLB
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Post-IPO - HLB | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HLB
HLB has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include E&Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HLB
HLB has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Anygen and GtreeBNT. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Peptide API and drug developer for cancer & pain disorders
|
2000 | ||||
|
Therapies for brain cancer treatment are developed by GtreeBNT.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - HLB
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hlb Comparisons
Competitors of HLB
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hlb
Frequently Asked Questions about HLB
When was HLB founded?
HLB was founded in 1985 and raised its 1st funding round 32 years after it was founded.
Where is HLB located?
HLB is headquartered in Ulsan, South Korea.
Who is the current CEO of HLB?
Jin Yang Gon is the current CEO of HLB.
How many employees does HLB have?
As of Dec 31, 2024, the latest employee count at HLB is 168.
What is the annual revenue of HLB?
Annual revenue of HLB is $46.19M as on Dec 31, 2024.
What does HLB do?
HLB, established in 1985 and currently in Public stage, focuses on manufacturer of marine composite materials. Manufacturer of marine composite materials. Adapting to market demands with innovation. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
What products or services does HLB offer?
HLB offers Rivoceranib and Other Therapies.
Is HLB publicly traded?
Yes, HLB is publicly traded on KRX under the ticker symbol 028300.
Who are HLB's investors?
HLB has 1 investor. Key investors include E&Investment.
What is HLB's ticker symbol?
The ticker symbol of HLB is 028300 on KRX.